前列腺癌的前景:南美洲多学科瘤学方法的进展和未决挑战
Kevin A Diaz1, Sandra Liliana Amaya1, Herney Andrés García-Perdomo2,3
1UROGIV Research Group, Department of Surgery, School of Medicine, Universidad del Valle, Cll 4B #36-00, Cali, Colombia.
International urology and nephrology
|September 12, 2023
概括
南美洲的前列腺癌管理面临挑战,因为早期检测和获得专门护理的机会有限. 转诊中心的多学科方法可以改善前列腺癌患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 公共卫生 公共卫生
背景情况:
- 前列腺癌是全球男性癌症发病率和死亡率的主要原因,区域差异很大.
- 南美国家在前列腺癌护理方面面临着独特的挑战,包括不一致的流行病学数据,低的早期检测率,以及对先进的诊断和多学科治疗的限制.
- 在护理方面存在差异,大多数患者由非专家管理,可能会影响预后.
研究的目的:
- 概述目前南美前列腺癌的临床管理.
- 突出该地区前列腺癌护理的最新进展和持续的局限性.
- 强调多学科方法的好处,涉及泌尿科医生,医疗瘤学家和专门的癌症中心的心理健康专业人员.
主要方法:
- 审查南美前列腺癌患者的临床管理策略.
- 对当前治疗进展和现有医疗保健系统局限性的分析.
- 探索多学科团队方法对患者结果的影响.
主要成果:
- 南美洲前列腺癌的流行病学数据高度可变,通常受诊断可访问性和数据收集质量等因素的影响.
- 获得最先进的诊断和专业的多学科治疗往往集中在城市转诊中心,使得很大一部分人口缺乏服务.
- 由于资源有限,非专家泌尿科医生的低最佳护理可能会对患者的预后产生负面影响.
结论:
- 解决前列腺癌数据的变异性和改善早期检测对于南美医疗保健系统至关重要.
- 提高获得专门的多学科护理的机会,特别是在转诊中心,对于改善瘤治疗结果至关重要.
- 与专门的泌尿科医生,医疗瘤学家和心理健康专业人员一起实施综合护理模式,可以优化前列腺癌患者的管理和结果.
更多相关视频
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
706
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.6K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
